Innotox 50U

Innotox 50U represents a major breakthrough in medical aesthetics as the world’s first liquid Botulinum Toxin Type A. Developed by Medytox, a pioneer in South Korean biopharmaceuticals, this innovative neurotoxin arrives in a pre-mixed, ready-to-use liquid state. By eliminating the traditional, time-consuming reconstitution process required by powder-based toxins, Innotox provides unparalleled convenience for practitioners and minimizes the risk of cross-contamination.

Because there is no need for manual dilution, Innotox removes the margin for human error, guaranteeing that each 0.1 mL injection delivers exactly 4 units of the active product. Furthermore, Medytox prioritizes patient safety by formulating Innotox without human serum albumin (HSA) or animal-derived ingredients. Instead, it utilizes natural stabilizers like L-methionine and polysorbate, significantly reducing the risk of allergic reactions and illnesses related to blood-derived excipients.

Innotox 50U is highly effective for the temporary improvement of moderate to severe facial wrinkles, particularly glabellar lines caused by the activity of the corrugator and procerus muscles. Thanks to its unique liquid matrix, the solution features a low diffusion rate, ensuring the toxin stays localized at the injection site without relaxing unintended adjacent muscles. Patients generally notice visible smoothing within a few days of treatment, with natural-looking results that can last up to 6 months.